Neby Bekele

410 total citations
6 papers, 164 citations indexed

About

Neby Bekele is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Neby Bekele has authored 6 papers receiving a total of 164 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Molecular Biology, 2 papers in Pulmonary and Respiratory Medicine and 2 papers in Oncology. Recurrent topics in Neby Bekele's work include HER2/EGFR in Cancer Research (2 papers), Acute Myeloid Leukemia Research (1 paper) and RNA modifications and cancer (1 paper). Neby Bekele is often cited by papers focused on HER2/EGFR in Cancer Research (2 papers), Acute Myeloid Leukemia Research (1 paper) and RNA modifications and cancer (1 paper). Neby Bekele collaborates with scholars based in United States. Neby Bekele's co-authors include Ara A. Vaporciyan, Ashleigh M. Francis, Jack A. Roth, Shanda H. Blackmon, Wayne L. Hofstetter, Dipen M. Maru, Jaffer A. Ajani, Tsung Teh Wu, David C. Rice and Arlene M. Correa and has published in prestigious journals such as Gastroenterology, The Annals of Thoracic Surgery and Molecular Cancer Therapeutics.

In The Last Decade

Neby Bekele

6 papers receiving 163 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Neby Bekele United States	4	93	84	57	29	20	6	164
Anjali Narayan Avadhani United States	8	42 0.5×	95 1.1×	87 1.5×	64 2.2×	10 0.5×	20	178
Natalie Q. Wang Canada	2	111 1.2×	79 0.9×	24 0.4×	53 1.8×	28 1.4×	2	172
J. Samuel United Kingdom	5	73 0.8×	52 0.6×	81 1.4×	110 3.8×	29 1.4×	8	205
Kate Weiss United States	5	73 0.8×	42 0.5×	61 1.1×	40 1.4×	31 1.6×	7	143
Noriaki Morofuji Japan	7	44 0.5×	78 0.9×	51 0.9×	66 2.3×	18 0.9×	15	151
Laura Ginocchi Italy	8	67 0.7×	44 0.5×	47 0.8×	119 4.1×	26 1.3×	17	183
Elias Abdo Filho Brazil	5	36 0.4×	106 1.3×	44 0.8×	105 3.6×	23 1.1×	10	264
P. Céliz Spain	3	33 0.4×	87 1.0×	36 0.6×	41 1.4×	21 1.1×	7	126
Eduardo Barrascout France	4	122 1.3×	27 0.3×	61 1.1×	91 3.1×	40 2.0×	7	156
Catarina Silveira Portugal	6	58 0.6×	32 0.4×	57 1.0×	53 1.8×	44 2.2×	13	148

Countries citing papers authored by Neby Bekele

Since Specialization

Citations

This map shows the geographic impact of Neby Bekele's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neby Bekele with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neby Bekele more than expected).

Fields of papers citing papers by Neby Bekele

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neby Bekele. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neby Bekele. The network helps show where Neby Bekele may publish in the future.

Co-authorship network of co-authors of Neby Bekele

This figure shows the co-authorship network connecting the top 25 collaborators of Neby Bekele. A scholar is included among the top collaborators of Neby Bekele based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neby Bekele. Neby Bekele is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Tolcher, Anthony W., Andrae Vandross, Melissa M. Johnson, et al.. (2022). A dose-escalation and expansion study of the safety and pharmacokinetics of XB002 in subjects with inoperable locally advanced or metastatic solid tumors (301). Gynecologic Oncology. 166. S158–S158. 2 indexed citations

2.

Tsimberidou, Apostolia M., Michael J. Keating, Elias Jabbour, et al.. (2014). A Phase I Study of Fludarabine, Cytarabine, and Oxaliplatin Therapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia. Clinical Lymphoma Myeloma & Leukemia. 14(5). 395–400.e1. 7 indexed citations

3.

Jacobson, Ira M., Christopher Christensen, Brian Conway, et al.. (2014). 647 Sofosbuvir-Based Regimens Are Associated With High SVR Rates Across Genotypes and Among Patients With Multiple Negative Predictive Factors. Gastroenterology. 146(5). S–920. 2 indexed citations

4.

Hofstetter, Wayne L., Arlene M. Correa, Neby Bekele, et al.. (2007). Proposed Modification of Nodal Status in AJCC Esophageal Cancer Staging System. The Annals of Thoracic Surgery. 84(2). 365–375. 84 indexed citations

5.

Wu, Wenjuan, Michael S. O’Reilly, Robert R. Langley, et al.. (2007). Expression of epidermal growth factor (EGF)/transforming growth factor-α by human lung cancer cells determines their response to EGF receptor tyrosine kinase inhibition in the lungs of mice. Molecular Cancer Therapeutics. 6(10). 2652–2663. 34 indexed citations

6.

Wang, Luo, Marivonne Rodriguez, Edward S. Kim, et al.. (2004). A novel C/T polymorphism in the core promoter of human de novo cytosine DNA methyltransferase 3B6 is associated with prognosis in head and neck cancer.. International Journal of Oncology. 25(4). 993–1002. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact